| P50 | author | Bernard H Bochner | Q42862211 |
| P2093 | author name string | Y Chen | |
| | M P Porter | |
| | T M Koppie | |
| | C L Amling | |
| | T M Downs | |
| | A B Apolo | |
| | J C La Rochelle | |
| | N G Cowan | |
| P2860 | cites work | Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. | Q30374602 |
| | Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration | Q30991559 |
| | Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base | Q33287299 |
| | Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer | Q34226107 |
| | International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial | Q35023400 |
| | Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival | Q36413226 |
| | Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion | Q36628852 |
| | Defining optimal therapy for muscle invasive bladder cancer | Q36707709 |
| | Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer | Q37787119 |
| | Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. | Q37859970 |
| | A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer | Q38017042 |
| | ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings. | Q38037274 |
| | Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire | Q44318708 |
| | Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: which patients benefit? | Q44793758 |
| | Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. | Q51939874 |
| | Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007 | Q58463292 |
| | Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists | Q78201097 |
| | Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage | Q79075055 |
| | Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach | Q84153499 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | bladder cancer | Q504775 |
| P304 | page(s) | 746298 | |
| P577 | publication date | 2014-05-28 | |
| P1433 | published in | Advances in Urology | Q15756218 |
| P1476 | title | Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions | |
| P478 | volume | 2014 | |